Loading clinical trials...
Loading clinical trials...
Efficacy and Safety Comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Versus Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Vehicle Gel as a 6-month Acne Maintenance Treatment
Conditions
Interventions
Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel
Vehicle Gel
Locations
33
United States
Galderma Investigational Site
San Diego, California, United States
Galderma Investigational Site
Denver, Colorado, United States
Galderma Investigational Site
Longmont, Colorado, United States
Galderma Investigational Site
Miami, Florida, United States
Galderma Investigational Site
Snellville, Georgia, United States
Galderma Investigational Site
Chicago, Illinois, United States
Start Date
November 1, 2008
Primary Completion Date
July 1, 2009
Completion Date
July 1, 2009
Last Updated
February 18, 2021
NCT07058883
NCT07406893
NCT07368764
NCT07205107
NCT07151599
NCT05639933
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions